Sort by
Refine Your Search
-
in the following five thematic areas: 1. Theme 1 (“Nowcasting”): Hybrid Physics-AI for Short-term Weather and Hydrologic Prediction Skillful predictions of weather and hydrology in the short-term (few
-
fellowship legacy project. Other Opportunities Fellows will also have the opportunity to tailor their experience by engaging in optional cross-functional projects or short-term rotations across key departments
-
cross-functional projects or short-term rotations across key departments based on individual interest and organizational need. These may include areas such as: Field Medical Evidence Generation Medical
-
experiences, and how they process social information. We also examine how individual differences in these processes confer risk or resilience to mental health problems. As part of the Center for Cognitive and
-
gastrointestinal (GI) and rare diseases. Ironwood is advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for short bowel syndrome patients who are dependent on parenteral
-
, long-acting synthetic GLP-2 analog being developed for short bowel syndrome patients who are dependent on parenteral support. In addition, Ironwood has been a pioneer in the development of LINZESS
-
. About Eidos and BridgeBio Pharma Inc. BridgeBio Pharma, Inc. (BridgeBio/BBIO) is a biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who
-
(Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent
-
Learning Seminar series Facilitate small and large group didactic education in partnership with a faculty mentor Create, present, and publish scholarly research through collaborative industry and university
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more